DELIC" or the " Company") (CSE: DELC) (OTCQB: DELCF), a psychedelic wellness-focused company, is pleased to provide the following shareholder update on its operations for the first quarter of 2021. The first quarter of 2021 has been transformative and expansive as DELIC has entered into new sectors of this nascent industry. From early beginnings in media with Reality Sandwich, Meet DELIC, & DELIC Radio, DELIC now has begun to execute its M&A strategy by entering into binding agreements with Ketamine Infusion Center ("KIC"), with their clinics located in California and Arizona, and of Complex Biotech Discovery Ventures ("CBDV") in Vancouver, and more. Acquisition Transactions: